These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6833559)

  • 1. Diatrizoate CT distribution kinetics: a study of human tissue characterization.
    Oppenheimer DA; Young SW
    J Comput Assist Tomogr; 1983 Apr; 7(2):274-7. PubMed ID: 6833559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic potential of contrast enhancement pharmacokinetics.
    Dean PB; Kivisaari L; Kormano M
    Invest Radiol; 1978; 13(6):533-40. PubMed ID: 755032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic computed tomography time--density study of normal human tissue after intravenous contrast administration.
    Young SW; Noon MA; Marincek B
    Invest Radiol; 1981; 16(1):36-9. PubMed ID: 7216694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomes carrying diatrizoate. Characterization of biophysical properties and imaging applications.
    Seltzer SE; Davis MA; Adams DF; Shulkin PM; Landis WJ; Havron A
    Invest Radiol; 1984; 19(2):142-51. PubMed ID: 6533105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choice of contrast material for four-hour delayed contrast-enhanced computed tomography of the liver.
    Feuerstein IM; Girton ME
    Invest Radiol; 1989 Oct; 24(10):776-80. PubMed ID: 2793390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle contrast-enhanced micro-CT: A preclinical tool for the 3D imaging of liver and spleen in longitudinal mouse studies.
    Liu CN; Morin J; Dokmanovich M; Bluette CT; Goldstein R; Manickam B; Bagi CM
    J Pharmacol Toxicol Methods; 2019; 96():67-77. PubMed ID: 30738209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particulate contrast media for computed tomographic scanning of the liver.
    Violante MR; Dean PB; Fischer HW; Mahoney JA
    Invest Radiol; 1980; 15(6 Suppl):S171-5. PubMed ID: 7203919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A strategy for the contrast enhancement of malignant tumors using dynamic computed tomography and intravascular pharmacokinetics.
    Young SW; Turner RJ; Castellino RA
    Radiology; 1980 Oct; 137(1 Pt 1):137-47. PubMed ID: 7422835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Work in progress: serial evaluation of tumor volume using computed tomography and contrast kinetics.
    Oppenheimer DA; Young SW; Marmor JB
    Radiology; 1983 May; 147(2):495-7. PubMed ID: 6836128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT densities in delayed iodine hepatic scanning.
    Perkerson RB; Erwin BC; Baumgartner BR; Phillips VM; Torres WE; Clements JL; Gedgaudas-McClees K; Bernardino ME
    Radiology; 1985 May; 155(2):445-6. PubMed ID: 3983398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Densitometry via CT scan of liver, spleen and kidneys with bolus-shaped liver contrast media by the intravenous route (author's transl)].
    Hübener KH
    Rofo; 1978 Sep; 129(3):289-97. PubMed ID: 151038
    [No Abstract]   [Full Text] [Related]  

  • 12. Contrast enhancement in abdominal CT: bolus vs. infusion.
    Burgener FA; Hamlin DJ
    AJR Am J Roentgenol; 1981 Aug; 137(2):351-8. PubMed ID: 6789645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT findings in hepatosplenic and renal candidiasis.
    Shirkhoda A
    J Comput Assist Tomogr; 1987; 11(5):795-8. PubMed ID: 3308988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of contrast media: experimental results in dog and man with CT implications.
    Gardeur D; Lautrou J; Millard JC; Berger N; Metzger J
    J Comput Assist Tomogr; 1980 Apr; 4(2):178-85. PubMed ID: 7365016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential changes in the CT numbers of the normal canine kidney following intravenous contrast administration. II: The renal medulla.
    Brennan RE; Curtis JA; Pollack HM; Weinberg I
    Invest Radiol; 1979; 14(3):239-45. PubMed ID: 468497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation on the renal clearance of metylglucamine diatrizoate and of sodium and metylglucamine diatrizoate (author's transl)].
    Michelassi PL; Rindi P; Pilone N; Simonetti F
    Radiol Med; 1979 Sep; 65(9):611-4. PubMed ID: 554248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of liver, kidney, and spleen volumes by computed tomography: an experimental study in dogs.
    Moss AA; Friedman MA; Brito AC
    J Comput Assist Tomogr; 1981 Feb; 5(1):12-4. PubMed ID: 7240486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Abdominal angio-CT: technique of injection and scanning (author's transl)].
    Rossi P; Giacobini E; D'Auria S; Tipaldi L; Simonetti G; Passariello R; Linguiti L; Bompiani C
    Radiol Med; 1981 Apr; 67(4):217-23. PubMed ID: 7313152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic enhancement and metastatic lesion conspicuity on CT scans: influence of intravenous glucagon and oral CT contrast material.
    Warshauer DM; Wehmueller MD; Molina PL; Muller KE; DeLuca MC; Lee JK
    Radiology; 1997 Feb; 202(2):394-8. PubMed ID: 9015064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The preparation and characterization of liposomes containing X-ray contrast agents.
    Ryan PJ; Davis MA; Melchior DL
    Biochim Biophys Acta; 1983 Mar; 756(1):106-10. PubMed ID: 6824745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.